Lv2
200 积分 2026-03-31 加入
Adjunctive fecal microbiota transplantation for major depressive disorder: A randomized, double-blind, placebo-controlled trial
8天前
已完结
Sample size of 12 per group rule of thumb for a pilot study
1个月前
已完结
A Randomized Control Trial of Nitazoxanide Versus Rifaximin in Preventing the Recurrence of Hepatic Encephalopathy
1个月前
已关闭
Development of a clinical hepatic encephalopathy staging scale
1个月前
已完结
Development of a clinical hepatic encephalopathy staging scale
1个月前
已完结
Engineered commensals for metabolic modulation of the gut-liver-brain axis
2个月前
已完结
Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome
2个月前
已完结
Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis
2个月前
已完结
Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease
2个月前
已完结
Rifaximin Improves Psychometric Performance and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy (The RIME Trial)
2个月前
已完结
皖公网安备34019202002308
